News Pfizer looks to confirm US licence for breast cancer pill Pfizer has filed late stage data with FDA.
News NICE recommends Afinitor, Xalkori, as cancer drug review con... NICE has recommended two cancer drugs, as it continues its review of treatments in the old Cancer Drugs Fund.
News Pfizer's hopes for cholesterol blockbuster dashed Sales of cancer drug Ibrance also fall short of expectations.
News Novartis' LEE011 on fast track to challenge Ibrance US regulator grants fast review for breast cancer drug.
News Debiopharm teams up with Merck KGaA and Pfizer in lung cance... Swiss biotech looks to combine small molecule drug with immunotherapy.
Oncology ASCO 2026: AbbVie on ADCs, chemotherapy, and the future of o... For years, ADCs have been positioned as an important addition to the oncology toolkit. But, could they eventually replace chemotherapy altogether?
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
